{"id":"W1990719422","doi":"10.1007/s10549-012-2157-7","title":"Risk of rash with the anti-HER2 dimerization antibody pertuzumab: a meta-analysis","year":2012,"lang":"en","type":"review","venue":"Breast Cancer Research and Treatment","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pertuzumab; Medicine; Rash; Internal medicine; Oncology; Trastuzumab; Incidence (geometry); Breast cancer; Docetaxel; Clinical trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001503097,0.0005994469,0.003972413,0.0008388711,0.0003392141,0.00009045327,0.0003077816,0.0001870029,0.001559701],"category_scores_gemma":[0.00002895556,0.0002547566,0.001236801,0.002829462,0.0007742984,0.00008279028,0.0001605486,0.0007503052,0.00003430229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000887903,"about_ca_system_score_gemma":0.00209834,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01731051,"about_ca_topic_score_gemma":0.001423074,"domain_scores_codex":[0.9945008,0.001346049,0.0005552848,0.0008158607,0.001827439,0.0009545597],"domain_scores_gemma":[0.9965138,0.0006349859,0.0003594024,0.001277997,0.0006945991,0.0005191672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003186727,0.00101162,0.005844434,0.004739133,0.3328665,0.00006593847,0.0002148841,0.000003746738,0.000003827044,0.00003797571,0.0001794647,0.6547138],"study_design_scores_gemma":[0.0009415917,0.001630233,0.006005903,0.0008908323,0.4551613,0.000209181,0.00008934411,0.00001249135,0.00001335824,0.000004219448,0.5347413,0.0003002127],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004046652,0.9932876,0.00002923409,0.0008507175,0.00002292811,0.003087877,0.001923586,0.0000229103,0.0003704501],"genre_scores_gemma":[0.01569978,0.9792815,0.00004861939,0.00001101348,0.0002467097,0.002208925,0.0004052573,0.00009843826,0.001999743],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6544136,"threshold_uncertainty_score":0.9999905,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.271116512031164,"score_gpt":0.5036414260120149,"score_spread":0.2325249139808509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}